Barbara Lopez Kunz
CIK: 0001679970
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)2 (66.7%)
Derivative conversions
Awards (A)1 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
APVO
Aptevo Therapeutics Inc.
Director
Discretionary Trading P&L
Holdings
About Kunz Barbara Lopez
Kunz Barbara Lopez (SEC CIK 0001679970) files insider reports with the SEC as Director of Aptevo Therapeutics Inc. (APVO).
Signal8 holds 3 ownership filings by Kunz Barbara Lopez, all Form 4s, filed between Jul 21, 2025 and Aug 10, 2026. Those filings report 3 transactions, from Jul 17, 2025 to Aug 6, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Kunz Barbara Lopez's filings is in SEATTLE, WA.
Recent filings by Kunz Barbara Lopez
Other insiders filing for Aptevo Therapeutics Inc. (APVO)
- Harsanyi Zsolt, Director
- Lamothe Jeffrey G., President and CEO
- Taylor Daphne, SVP, CFO
- Kwon SoYoung, SVP, GC, BD & Corp Affairs
- Huebner Dirk, SVP, CMO
- Grant Grady III, Director